TeraRecon joins ConcertAI network

By AuntMinnie.com staff writers

November 9, 2021 -- TeraRecon has been integrated into sister company ConcertAI and will launch its technologies on ConcertAI's Digital Clinical Trials Network.

The companies have established a single integrated network and set of artificial intelligence (AI)-enabled workflows available on a software-as-a-service (SaaS) basis for clinical research and clinical decision support applications.

Initial research studies have been launched using ConcertAI's network, with images acquired and analyzed by TeraRecon technologies, the company said. The combined companies now have clinical, engineering, and commercial locations in the U.S., Germany, Japan, and India.

TeraRecon was acquired in 2020 by ConcertAI's parent company, SymphonyAI, which operates business-to-business AI companies in a variety of industries.

AI can help overburdened radiologists, spur hospital innovation
In today's environment, radiologists are often being asked to do more with less and to do it faster. TeraRecon President Dan McSweeney describes how AI...
TeraRecon taps new president
TeraRecon has appointed Dan McSweeney as its new president. He will be responsible for expanding TeraRecon's reach in advanced visualization and enterprise...
Everyone wins when AI becomes seamless for radiologists
Budgetary pressures, digital infrastructure improvements, and other industry shifts signal a new role for artificial intelligence (AI) in radiology and...

Copyright © 2021 AuntMinnie.com

Last Updated mf 11/10/2021 9:09:52 AM